HealthCap IX has held its final closing, raising total commitments in excess of the target from a diverse investor base comprising established institutions, pension funds, and renowned investors within the life sciences sector. The strong support reflects continued confidence in HealthCap’s strategy and proven track record.
HealthCap is a European venture capital firm investing globally in life sciences and has raised nine funds since 1996. HealthCap has backed and built more than 130 companies, taken more than 45 companies public, and completed numerous trade sales. The investment strategy focuses on diseases with a high unmet medical need and breakthrough therapies that have the potential to be transformative, change clinical practice, and change the lives of patients suffering from these conditions.
Vinge's team primarily consisted of Mattias Schömer, Marcus Andersson, Semir Omerbasic, Jesper Ottergren, Emelie Svanberg, Erik Kochbati and Emelie Zingmark.
